Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: A case control study

BMC Infectious Diseases

Volumn 5, Issue , 2005, Pages

  Chan, K C Allen ^a   Tang, Nelson L S ^a   Hui, David S C ^a   Chung, Grace T Y ^a   Wu, Alan K L ^a   Chim, Stephen S C ^a   Chiu, Rossa W K ^a   Lee, Nelson ^a   Choi, K W ^a   Sung, Y Mandy ^a   Chan, Paul K S ^a   Tong, Y K ^a   Lai, S T ^b   Yu, W C ^b   Tsang, Owen ^b   Lo, Y M Dennis ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGAR GEL ELECTROPHORESIS; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENDER; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; SEVERE ACUTE RESPIRATORY SYNDROME; VOLUNTEER;

EID: 25444516565     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-5-26     Document Type: Article

References (19)

1. WHO: Cumulative number of reported probable cases of SARS. http://wwwwhoint/csr/sars/country/2003_07)11/en/ 2004.
2. Tsui PT, Kwok ML, Yuen H, Lai ST: Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis 2003, 9:1064-1069.
3. Leung GM, Hedley AJ, Ho LM, Chau P, Wong IO, Thach TQ, Ghani AC, Donnelly CA, Fraser C, Riley S, Ferguson NM, Anderson RM, Tsang T, Leung PY, Wong V, Chan JC, Tsui E, Lo SV, Lam TH: The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med 2004, 141:662-673.
4. Chan MH, Wong VW, Wong CK, Chan PK, Chu CM, Hui DS, Suen MW, Sung JJ, Chung SS, Lam CW: Serum LD1 isoenzyme and blood lymphocyte subsets as prognostic indicators for severe acute respiratory syndrome. J Intern Med 2004, 255:512-518.
5. Ng EKO, Hui DS, Chan KCA, Hung EC, Chiu RWK, Lee N, Wu A, Chim SSC, Tong YK, Sung JJ, Tam JS, Lo YMD: Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome. Clin Chem 2003, 49:1976-1980.
6. Chim SSC, Tsui SK, Chan KCA, Au TC, Hung EC, Tong YK, Chiu RWK, Ng EK, Chan PKS, Chu CM, Sung JJ, Tam JS, Fung KP, Waye MM, Lee CY, Yuen KY, Lo YMD: Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong. Lancet 2003, 362:1807-1808.
7. Ng MH, Lau KM, Li L, Cheng SH, Chan WY, Hui PK, Zee B, Leung CB, Sung JJ: Association of human-leukocyte-antigen class I (B*703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome. J Infect Dis 2004, 190:515-8. Epub 2004 Jul 07..
8. Lin M, Tseng HK, Trejaut JA, Lee HL, Loo JH, Chu CC, Chen PJ, Su YW, Lim KH, Tsai ZU, Lin RY, Lin RS, Huang CH: Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet 2003, 4:9.
9. Chiu RWK, Tang NL, Hui DS, Chung GT, Chim SSC, Chan KCA, Sung YM, Chan LY, Tong YK, Lee WS, Chan PK, Lo YMD: ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome. Clin Chem 2004, 50:1683-1686.
10. Itoyama S, Keicho N, Quy T, Phi NC, Long HT, Ha le D, Ban VV, Ohashi J, Hijikata M, Matsushita I, Kawana A, Yanai H, Kirikae T, Kuratsuji T, Sasazuki T: ACE1 polymorphism and progression of SARS. Biochem Biophys Res Commun 2004, 323:1124-1129.
11. WHO: Case Definitions for Surveillance of Severe Acute Respiratory Syndrome (SARS). http://wwwwhoint/csr/sars/casedefinition/en/ 2004.
12. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
13. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, Humphries SE, Hill MR, Laurent GJ: Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002, 166:646-650.
14. Zhao B, Moochhala SM, Tham S, Lu J, Chia M, Byrne C, Hu Q, Lee LK: Relationship between angiotensin-converting enzyme ID polymorphism and VO(2max) of Chinese males. Life Sci 2003, 73:2625-2630.
15. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F: Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993, 290:33-40.
16. Koh WP, Yuan JM, Sun CL, van den Berg D, Seow A, Lee HP, Yu MC: Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res 2003, 63:573-578.
17. Tse GM, To KF, Chan PK, Lo AW, Ng KC, Wu A, Lee N, Wong HC, Mak SM, Chan KF, Hui DS, Sung JJ, Ng HK: Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). J Clin Pathol 2004, 57:260-265.
18. Colhoun HM, McKeigue PM, Davey Smith G: Problems of reporting genetic associations with complex outcomes. Lancet 2003, 361:865-872.
19. Daly AK, Day CP: Candidate gene case-control association studies: advantages and potential pitfalls. Br J Clin Pharmacol 2001, 52:489-499.